BillionToOne is trading 4.15% higher at $101.94 on October 15, 2026, with no clear company-specific announcement explaining the move. - The latest company release listed a date for third-quarter results. - The Northstar Response study was announced October 7, not today. - Biotech-sector strength may be supportive, with XBI up 2.20% in the regular session; available evidence does not establish a direct cause.